BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2463900)

  • 1. [Neuromodulators and Alzheimer's disease].
    Vallet PG; Bouras C
    Encephale; 1988; 14(5):345-51. PubMed ID: 2463900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
    Beal MF; MacGarvey U; Swartz KJ
    Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptides in Alzheimer's disease.
    Beal MF; Kowall NW; Mazurek MF
    J Neural Transm Suppl; 1987; 24():163-74. PubMed ID: 2445913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropathology of Alzheimer's disease and mild cognitive impairment].
    López OL; DeKosky ST
    Rev Neurol; 2003 Jul 16-31; 37(2):155-63. PubMed ID: 12938076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitters and neuropeptides in Alzheimer's disease.
    McDonald WM; Nemeroff CB
    Psychiatr Clin North Am; 1991 Jun; 14(2):421-42. PubMed ID: 1676509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senile dementia of the Alzheimer type.
    Terry RD; Katzman R
    Ann Neurol; 1983 Nov; 14(5):497-506. PubMed ID: 6139975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders.
    Mann DM; Yates PO
    Hum Neurobiol; 1986; 5(3):147-58. PubMed ID: 2876973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
    Kowall NW; Beal MF
    Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurochemistry of Alzheimer's disease.
    Engelborghs S; De Deyn PP
    Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurotransmitters in Alzheimer's disease].
    Kristensen MO
    Ugeskr Laeger; 1990 Jul; 152(30):2165-8. PubMed ID: 1975961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides in neurological disease.
    Beal MF; Martin JB
    Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropeptides in Alzheimer's disease].
    Jiménez-Corral C; Morán-Sánchez JC; Alonso-Navarro H
    Rev Neurol; 2006 Mar 16-31; 42(6):354-9. PubMed ID: 16575772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropeptides and Alzheimer's disease].
    Jiménez A; Astarloa R; Morales B
    Neurologia; 1991 Jan; 6(1):17-24. PubMed ID: 1677810
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological correlates of cognitive decline in Alzheimer's disease.
    Thind K; Sabbagh MN
    Panminerva Med; 2007 Dec; 49(4):191-5. PubMed ID: 18091671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
    Heilig M; Sjögren M; Blennow K; Ekman R; Wallin A
    Biol Psychiatry; 1995 Aug; 38(4):210-6. PubMed ID: 8547442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nicotinic acetylcholine receptors in Alzheimer's disease.
    Oddo S; LaFerla FM
    J Physiol Paris; 2006; 99(2-3):172-9. PubMed ID: 16448808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.